{"title": "Conjunctival polymerase chain reaction-tests of 2019 novel coronavirus in patients in Shenyang,China", "doi": "10.1101/2020.02.23.20024935", "citation_id": "2020.02.23.20024935v1", "date": "2020-02-25", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.23.20024935", "abstract": "<p>Purpose: The 2019 novel coronavirus(COVID-19) mainly transmitted by person-to-person through inhalation of respiratory droplets. We report the laboratory results of conjunctival PCR-tests and some clinical features of these patients in shenyang China.\nDesign: This is a cross-sectional non-randomized study.\nSubjects: The study include 14 confirmly diagnosed cases, 16 suspected cases and some medical observed patients.\nMethods:  All patients with diagnosed and suspected COVID-19 were admitted to a designated hospital in Shenyang,China. We  collected  conjunctival samples of these patients to do the laboratory tests by real time RT-PCR.Medical observed patients were enrolled if they had clinical symptoms. Then we analysed the PCR results and clinical data from eletronic medical records in order to find some relationships.\nMain Outcome Measures: Clinical condition and PCR results of conjunctival swabs compared with other specimens.\nResults:\nOne of the identified case coverted from suspected case without typical clinical symptoms. Twenty-two medical observed cases  were removed because none of them converted to identified cases.One of the suspected converted to identified case recently.The included cases in our study are imported cases with less underlying diseases and the severity of their infection was relatively moderate. All the conjunctival results of PCR-test were negative. Two cases had typical clinical symptoms but were finally confirmed by repeated pharynx swab tests.\nConclusion: Conjunctiva may be a transmission way of COVID-19. And ocular conjunctival swabs in combination with PCR test could be a non-invasive,convenient and feasible diagnostic method for identifying the infection of COVID-19. Emphasis on the false-negative results is vital.</p>", "twitter_description": "Purpose: The 2019 novel coronavirus(COVID-19) mainly transmitted by person-to-person through inhalation of respiratory droplets. We report the laboratory results of conjunctival PCR-tests and some clinical features of these patients in shenyang China. Design: This is a cross-sectional non-randomized study. Subjects: The study include 14 confirmly diagnosed cases, 16 suspected cases and some medical observed patients. Methods: All patients with diagnosed and suspected COVID-19 were admitted to a designated hospital in Shenyang,China. We collected conjunctival samples of these patients to do the laboratory tests by real time RT-PCR.Medical observed patients were enrolled if they had clinical symptoms. Then we analysed the PCR results and clinical data from eletronic medical records in order to find some relationships. Main Outcome Measures: Clinical condition and PCR results of conjunctival swabs compared with other specimens. Results: One of the identified case coverted from suspected case without typical clinical symptoms. Twenty-two medical observed cases were removed because none of them converted to identified cases.One of the suspected converted to identified case recently.The included cases in our study are imported cases with less underlying diseases and the severity of their infection was relatively moderate. All the conjunctival results of PCR-test were negative. Two cases had typical clinical symptoms but were finally confirmed by repeated pharynx swab tests. Conclusion: Conjunctiva may be a transmission way of COVID-19. And ocular conjunctival swabs in combination with PCR test could be a non-invasive,convenient and feasible diagnostic method for identifying the infection of COVID-19. Emphasis on the false-negative results is vital.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nMinistry of Shenyang science and technology\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nthe data are all in the manuscript", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.23.20024935v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.23.20024935v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.23.20024935v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/02/25/2020.02.23.20024935.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.23.20024935v1", "access_rights": "restricted", "authors": ["li Xu", "Xinyue Zhang", "Wei Song", "Baijun Sun", "Jinping Mu", "Xue Dong", "Bing Wang"]}